BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12738665)

  • 1. Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.
    Jones B; Adams S; Miller GT; Jesson MI; Watanabe T; Wallner BP
    Blood; 2003 Sep; 102(5):1641-8. PubMed ID: 12738665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
    Adams S; Miller GT; Jesson MI; Watanabe T; Jones B; Wallner BP
    Cancer Res; 2004 Aug; 64(15):5471-80. PubMed ID: 15289357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
    Wu W; Liu Y; Milo LJ; Shu Y; Zhao P; Li Y; Woznica I; Yu G; Sanford DG; Zhou Y; Poplawski SE; Connolly BA; Sudmeier JL; Bachovchin WW; Lai JH
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5536-40. PubMed ID: 22853995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
    Connolly BA; Sanford DG; Chiluwal AK; Healey SE; Peters DE; Dimare MT; Wu W; Liu Y; Maw H; Zhou Y; Li Y; Jin Z; Sudmeier JL; Lai JH; Bachovchin WW
    J Med Chem; 2008 Oct; 51(19):6005-13. PubMed ID: 18783201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphostin, a novel inhibitor of dipeptidyl peptidases IV (DPPIV) that stimulates hematopoiesis in mice.
    Abe M; Abe F; Nishimura C; Ichimura E; Ogasawara A; Ichinei M; Muraoka Y; Saino T
    J Antibiot (Tokyo); 2005 Feb; 58(2):111-7. PubMed ID: 15835723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
    Flentke GR; Munoz E; Huber BT; Plaut AG; Kettner CA; Bachovchin WW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1556-9. PubMed ID: 1671716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy.
    Nemunaitis J; Vukelja SJ; Richards D; Cunningham C; Senzer N; Nugent J; Duncan H; Jones B; Haltom E; Uprichard MJ
    Cancer Invest; 2006 Oct; 24(6):553-61. PubMed ID: 16982458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV (CD26) activity in the hematopoietic system: differences between the membrane-anchored and the released enzyme activity.
    Pereira DA; Gomes L; El-Cheikh MC; Borojevic R
    Braz J Med Biol Res; 2003 May; 36(5):567-78. PubMed ID: 12715075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p38 in regulation of hematopoiesis: effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells.
    Scicchitano MS; McFarland DC; Tierney LA; Boyce RW; Frazier KS; Schwartz LW; Thomas HC
    Blood Cells Mol Dis; 2008; 40(3):370-80. PubMed ID: 18093851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of N-alkyl Gly-boro-Pro inhibitors of DPP4, FAP, and DPP7.
    Hu Y; Ma L; Wu M; Wong MS; Li B; Corral S; Yu Z; Nomanbhoy T; Alemayehu S; Fuller SR; Rosenblum JS; Rozenkrants N; Minimo LC; Ripka WC; Szardenings AK; Kozarich JW; Shreder KR
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4239-42. PubMed ID: 16085416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides.
    Coutts SJ; Kelly TA; Snow RJ; Kennedy CA; Barton RW; Adams J; Krolikowski DA; Freeman DM; Campbell SJ; Ksiazek JF; Bachovchin WW
    J Med Chem; 1996 May; 39(10):2087-94. PubMed ID: 8642568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
    Moore MA; Warren DJ
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV.
    Tsu H; Chen X; Chen CT; Lee SJ; Chang CN; Kao KH; Coumar MS; Yeh YT; Chien CH; Wang HS; Lin KT; Chang YY; Wu SH; Chen YS; Lu IL; Wu SY; Tsai TY; Chen WC; Hsieh HP; Chao YS; Jiaang WT
    J Med Chem; 2006 Jan; 49(1):373-80. PubMed ID: 16392822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of two dipeptidyl aminopeptidases II from rat brain and their action on proline-containing neuropeptides.
    Mentlein R; Struckhoff G
    J Neurochem; 1989 Apr; 52(4):1284-93. PubMed ID: 2564425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.
    Pojda Z; Tanaka K; Aoki Y; Tsuboi A
    Exp Hematol; 1992 Aug; 20(7):874-8. PubMed ID: 1378408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
    Christopherson KW; Cooper S; Broxmeyer HE
    Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV.
    Tanaka S; Murakami T; Horikawa H; Sugiura M; Kawashima K; Sugita T
    Int J Immunopharmacol; 1997 Jan; 19(1):15-24. PubMed ID: 9226475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.